HIV positive pregnant women receiving antiretrovirals … high in Uganda
Uganda: HIV positive pregnant women receiving antiretrovirals … high was 52.0% in 2011. ◆ Volatile
HIV positive pregnant women receiving antiretrovirals, using in Uganda, 2004–2011
Source: http://data.unaids.org/pub/GlobalReport/2008/. Measured in %; high estimate.
Analysis
The most recent figure for hiv positive pregnant women receiving antiretrovirals, using in Uganda is 52.0%, measured in 2011.
The figure is down 45.3% on the previous year and up 420.0% over ten years.
Uganda ranks 25th of 38 countries on this measure, in the middle of the range.
HIV positive pregnant women receiving antiretrovirals … high in Uganda, year by year
| Year | %; high estimate | Change |
|---|---|---|
| 2004 | 10.0% | — |
| 2005 | 17.0% | +70.0% |
| 2006 | 28.0% | +64.7% |
| 2007 | 39.0% | +39.3% |
| 2009 | 95.0% | +143.6% |
| 2011 | 52.0% | -45.3% |
Uganda compared with similar countries
- Uganda's 52.0% is below the median for Sub-Saharan Africa, which is 62.0%, 84% of the median. (38 countries reporting)
- Uganda's 52.0% is below the median for low income countries, which is 54.0%, 96% of the median. (17 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 37.8% | 10.0% | 95.0% | 5 |
| 2010s | 52.0% | 52.0% | 52.0% | 1 |
Countries ranked near Uganda
More health data for Uganda
- Un projection of annual infant deaths, annual growth rate -2.2 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.34 % change on previous year (2090)
- Un projection of annual infant deaths 6,666 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 111 (2025)
- Population ages 00-04, female, annual growth rate 1.28 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0787 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.34 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0804 units per person (2025)
Frequently asked questions
- What is hiv positive pregnant women receiving antiretrovirals, using in Uganda?
- Hiv positive pregnant women receiving antiretrovirals, using in Uganda was 52.0% in 2011, according to http://data.unaids.org/pub/GlobalReport/2008/.
- What is the highest hiv positive pregnant women receiving antiretrovirals, using recorded in Uganda?
- The highest recorded value was 95.0% in 2009.
- What is the lowest hiv positive pregnant women receiving antiretrovirals, using recorded in Uganda?
- The lowest recorded value was 10.0% in 2004.
- How does Uganda rank for hiv positive pregnant women receiving antiretrovirals, using?
- Uganda ranks 25th out of 38 countries with data for 2011.
- Is hiv positive pregnant women receiving antiretrovirals, using rising or falling in Uganda?
- Over the last ten years it is up 420.0%. The long-run trend across the full record is volatile.
- Where does this Uganda data come from?
- The figures come from http://data.unaids.org/pub/GlobalReport/2008/, published as part of HIV positive pregnant women receiving antiretrovirals, using WHO/UNAIDS methodology (%; high estimate). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Percentage of HIV-infected pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission. Numerator: Number of HIV-infected pregnant women who received antiretrovirals during the last 12 months to reduce mother-to-child transmission. Denominator: Estimated number of HIV-infected pregnant women in the last 12 months. Ranges are presented for countries with low and concentrated epidemics. The purpose of this indicator is to assess progress in preventing vertical transmission of HIV. All data reflect values representing 12 month period ending December 2007 which have been reconciled between reporting country and UNAIDS/WHO/UNICEF, unless otherwise noted. All analysis of this indicator, including quoted country figures, reflect numerators which have gone through a tri agency reconciliation (UNAIDS/WHO/UNICEF) process and denominators which have been estimated directly from the UNAIDS/WHO Reference group on Estimates, Modelling and Projections methodology (Spectrum). The reconciliation process ensured all agencies reported the same country endorsed figure which was the most recent and met the definition of HIV-infected women receiving antiretroviral drugs over the last 12 months, and thus reflect a full year. Every effort was made in cases of discrepancy across the three agencies to obtain approval from the country on a final indicator value.